审稿人意见 帮忙翻一下啊
In the discussion, it would be good to divide it into initial comparision of results with current standard of care (sorafenib/ TACE + sorafenib). Thereafter consider comparision with studies focussing on other forms of aggressive PV tumour thrombus management such as SBRT, Endovascular RFA, hepatic artery infusion of chemotherapy (HAIC) etc. This section could have been more detailed to be able to highlight the comparibility of your technique with other published techniques.
最后编辑于 2022-10-09 · 浏览 2565